On May 30, 2025, Pfizer announced statistically significant and clinically meaningful survival results from the Phase 3 BREAKWATER…
On Apr. 23, 2025, researchers from the Wellcome Sanger Institute, University of California San Diego and their collaborators…
On Jan. 3, 2025, the U.S. General Dr. Vivek Murthy released a new Surgeon General’s Advisory on Alcohol…
On Dec. 20, 2024, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved BRAFTOVI® (encorafenib)…
On Jul. 31, 2024, a large study led by researchers at the American Cancer Society (ACS) suggested incidence…
On Mar. 13, 2024, the Fred Hutchinson Cancer Center announced that a blood test intended for screening for…
On Apr. 19, 2021, the Mayo Clinic announced a study that bolstered evidence that colorectal cancer is often…
May 4, 2018, scientists from the National Cancer Institute (NCI) reported that an analysis of a prevention clinical…
On Feb. 1, 2004, the U.S. Food and Drug Administration (FDA) announced it had approved Cetuximab, a recombinant…
On Sept. 3, 2003, the death rates from the four most common cancers, – lung, breast, prostate, and…
In 2003, two randomized controlled trials showed that taking aspirin daily for as little as three years reduces…
On Nov. 19, 1999, National Colorectal Cancer Awareness Month was established with a declaration by the U.S. Senate,…
In June 1996, the Food and Drug Administration (FDA) first approved irinotecan for the treatment of patients with…
On Dec. 2, 1993, Dana-Farber scientists identified the gene that causes an inherited form of colon cancer, which…
In 1993, the Prostate, Lung, Colorectal, and Ovarian trial was launched The trial was designed to determine whether…
In 1993, the Washington University School of Medicine announced that it was a participating site for the prostate,…